索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]凌浩 刘威武 侯秀伟 毕莲茹 陈庆宇 宋春莉.间充质干细胞源性外泌体在心血管疾病中的研究进展[J].国际心血管病杂志,2018,05:273-276.
点击复制

间充质干细胞源性外泌体在心血管疾病中的研究进展(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2018年05期
页码:
273-276
栏目:
综述
出版日期:
2019-02-01

文章信息/Info

Title:
-
作者:
凌浩 刘威武 侯秀伟 毕莲茹 陈庆宇 宋春莉
Author(s):
-
关键词:
间充质干细胞;  外泌体;  心血管疾病
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2018.05.005
文献标识码:
-
摘要:
间充质干细胞源性外泌体是间充质干细胞分泌的同质性膜囊泡,含有大量且种类繁多的蛋白质、细胞因子和微小RNA等生物活性物质,在心肌梗死、高血压、心力衰竭和心肌病等的防治方面有极高的应用前景
Abstract:
-

参考文献/References


[1] 张娟, 史晋叔, 李剑. 间充质干细胞源性外泌体——未来生物疗法的理想载体[J]. 中国实验血液学杂志, 2015, 23(4):1179-1183.
[2] Cheng X, Zhang G, Zhang L, et al. Mesenchymal stem cells deliver exogenous miR-21 via exosomes to inhibit nucleus pulposus cell apoptosis and reduce intervertebral disc degeneration[J]. J Cell Mol Med, 2018, 22(1):261-276.
[3] Arslan F, Lai RC, Smeets MB, et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury[J]. Stem Cell Res, 2013, 10(3):301-312.
[4] Lai RC, Chen TS, Lim SK. Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease[J]. Regen Med, 2011, 6(4):481-492.
[5] Smits AM, Van Vliet P, Hassink RJ, et al. The role of stem cells in cardiac regeneration[J]. J Cell Mol Med, 2005, 9(1):25-36.
[6] Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics[J]. Circ Res, 2004, 95(1):9-20.
[7] Rust PA, Kalsi P, Briggs TW, et al. Will mesenchymal stem cells differentiate into osteoblasts on allograft?[J]. Clin Orthop Relat Res, 2007, 457: 220-226.
[8] Morganstein DL, Wu P, Mane MR, et al. Human fetal mesenchymal stem cells differentiate into brown and white adipocytes: a role for ERRalpha in human UCP1 expression[J]. Cell Res, 2010, 20(4):434-444.
[9] Zhang XH, Hirai M, Cantero S, et al. Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells fro[J]. J Cell Biochem, 2011, 112(4):1206-1218.
[10] Xu Y, Meng H, Li C, et al. Umbilical cord-derived mesenchymal stem cells isolated by a novel explantation technique can differentiate into functional endothelial cells and promote revascularization[J]. Stem Cells Dev, 2010, 19(10):1511-1522.
[11] Silva GV, Litovsky S, Assad JA, et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model[J]. Circulation, 2005, 111(2):150-156.
[12] Khan M, Nickoloff E, Abramova T, et al. Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction[J]. Circ Res, 2015, 117(1):52-64.
[13] Huang L, Ma W, Ma Y, et al. Exosomes in mesenchymal stem cells, a new therapeutic strategy for cardiovascular diseases?[J]. Int J Biol Sci, 2015, 11(2):238-245.
[14] Hutcheson JD, Goettsch C, Bertazzo S, et al. Genesis and growth of extracellular-vesicle-derived microcalcification in atherosclerotic plaques[J]. Nat Mater, 2016, 15(3):335-343.
[15] Timmers L, Lim SK, Arslan F, et al. Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium[J]. Stem Cell Res, 2007, 1(2):129-137.
[16] Uemura R, Xu M, Ahmad N, et al. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling[J]. Circ Res, 2006, 98(11):1414-1421.
[17] Takaku M, Tomita S, Kurobe H, et al. Systemic preconditioning by a prolyl hydroxylase inhibitor promotes prevention of skin flap necrosis via HIF-1-induced bone marrow-derived cells[J]. PLoS ONE, 2012, 7(8):e42964.
[18] Bian S, Zhang L, Duan L, et al. Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model[J]. J Mol Med(Berl), 2014, 92(4):387-397.
[19] Zhang B, Wu X, Zhang X, et al. Human umbilical cord mesenchymal stem cell exosomes enhance angiogenesis through the Wnt4/β-catenin pathway[J]. Stem Cells Transl Med, 2015, 4(5):513-522.
[20] Wang R, Li N, Zhang Y, et al. Circulating microRNAs are promising novel biomarkers of acute myocardial infarction [J]. Internal Medicine, 2011, 50(17):1789-1795.
[21] Ti D, Hao H, Tong C, et al. LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b[J]. J Transl Med, 2015, 13:308.
[22] Aliotta JM, Pereira M, Wen SC, et al. Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice[J]. Cardiovasc Res, 2016, 110(3):319-330.
[23] Pironti G, Strachan RT, Abraham D, et al. Circulating exosomes induced by cardiac pressure overload contain functional angiotensin Ⅱ type 1 receptors[J]. Circulation, 2015, 131(24):2120-2130.
[24] Kontaraki JE, Marketou ME, Zacharis EA, et al. Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: novel targets in essential hypertension[J]. J Hum Hypertens, 2014, 28(8):510-516.
[25] Romaine SP, Charchar FJ, Samani NJ, et al. Circulating microRNAs and hypertension—from new insights into blood pressure regulation to biomarkers of cardiovascular risk[J]. Curr Opin Pharmacol, 2016, 27:1-7.
[26] Karolina DS, Tavintharan S, Armugam A, et al. Circulating miRNA profiles in patients with metabolic syndrome[J]. J Clin Endocrinol Metab, 2012, 97(12):e2271-e2276.
[27] Rosenberg M, Lutz M, Kühl C, et al. Coculture with hematopoietic stem cells protects cardiomyocytes against apoptosis via paracrine activation of AKT[J]. J Transl Med, 2012, 10:115.
[28] Feng Y, Huang W, Wani M, et al. Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22[J]. PLoS One, 2014, 9(2):e88685.
[29] Yu B, Gong M, Wang Y, et al. Cardiomyocyte protection by GATA-4 gene engineered mesenchymal stem cells is partially mediated by translocation of miR-221 in microvesicles[J]. PLoS One, 2013, 8(8):e73304.
[30] Vandergriff AC, De Andrade JB, Tang J, et al. Intravenous cardiac stem cell-derived exosomes ameliorate cardiac dysfunction in doxorubicin induced dilated cardiomyopathy[J]. Stem Cells Int, 2015, 2015:960926.
[31] Waldenström A, Ronquist G. Role of exosomes in myocardial remodeling[J]. Circ Res, 2014, 114(2):315-324.
[32] Salem ESB, Fan GC. Pathological effects of exosomes in mediating diabetic cardiomyopathy[J]. Adv Exp Med Biol, 2017, 998:113-138
[33] Zhang Y, Mignone J, Maclellan WR. Cardiac regeneration and stem cells[J]. Physiol Rev, 2015, 95(4):1189-1204.
[34] Konala VB, Mamidi MK, Bhonde R, et al. The current landscape of the mesenchymal stromal cell secretome: a new paradigm for cell-free regeneration[J]. Cytotherapy, 2016, 18(1):13-24.

备注/Memo

备注/Memo:
基金项目:吉林省新型冠脉支架科技创新中心(2017250); 2018年度吉林省财政厅卫生专项
作者单位:130012 长春,吉林大学第二医院心血管内科,吉林大学研究生院(凌浩,毕莲茹,陈庆宇); 130012 长春,吉林大学第二医院心血管内科(宋春莉,侯秀伟),放射科(刘威武)
通信作者:宋春莉,Email:2632494613@qq.com
更新日期/Last Update: 2018-09-30